InsidersTradesSigma
Explore the complete record of transactions filed by Landsittel Michael, Chief Financial Officer. Director active across 1 company, notably Blueprint Medicines Corp. Aggregated, 2 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €72k. History available since 1 March 2022. The latest transaction was filed on 3 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Michael Landsittel is the Chief Financial Officer of Blueprint Medicines Corp. In this role, he is responsible for the company's financial management, including financial planning and reporting. Michael Landsittel brings expertise in corporate finance and financial strategy, thereby contributing to the growth and sustainability of Blueprint Medicines Corp.